Salidroside Protects Against Advanced Glycation End Products-Induced Vascular Endothelial Dysfunction.

about

Salidroside Protects Against Advanced Glycation End Products-Induced Vascular Endothelial Dysfunction.

Item

http://www.wikidata.org/entity/Q52573088

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Salidroside Protects Against A ...... cular Endothelial Dysfunction.

@en

Salidroside Protects Against A ...... cular Endothelial Dysfunction.

@nl

type

Item

label

Salidroside Protects Against A ...... cular Endothelial Dysfunction.

@en

Salidroside Protects Against A ...... cular Endothelial Dysfunction.

@nl

prefLabel

Salidroside Protects Against A ...... cular Endothelial Dysfunction.

@en

Salidroside Protects Against A ...... cular Endothelial Dysfunction.

@nl

P1476

Salidroside Protects Against A ...... scular Endothelial Dysfunction

@en

P2093

Peng Zhang

http://www.w3.org/2001/XMLSchema#string

Rong Guo

http://www.w3.org/2001/XMLSchema#string

Wangfu Zang

http://www.w3.org/2001/XMLSchema#string

Yuanmin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders

Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease

Molecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 Diabetes

Diabetes and Clinical and Subclinical CVD.

Salidroside stimulates mitochondrial biogenesis and protects against H₂O₂-induced endothelial dysfunction.

Anti-Inflammatory and Neuroprotective Effects of Constituents Isolated from Rhodiola rosea

Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway.

Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.

Salidroside decreases atherosclerotic plaque formation in low-density lipoprotein receptor-deficient mice.

Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis

P304

2420-2428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.906064

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29679467

http://www.w3.org/2001/XMLSchema#string

P932

5930974

http://www.w3.org/2001/XMLSchema#string